CD8A and Miyoshi myopathy: SLAMF7 was substantially expressed on CD8+ T cells from MM patients (the percentage of CD8+ T cells expressing SLAMF7 varied between 1% and 92.7%, mean = 50.2%, Fig. 1a and Supplementary Fig. S1A).